##  [Higher dose of Novartis drug Exelon® Patch approved by FDA for patients with mild to moderate Alzheimer's disease](/us-en/news/media-releases/higher-dose-novartis-drug-exelon-patch-approved-fda-patients-mild-moderate-alzheimers-disease-0 "Higher dose of Novartis drug Exelon® Patch approved by FDA for patients with mild to moderate Alzheimer's disease") 

  Sep 04, 2012